DexCom

YTD

ALL

Trade DexCom 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About DXCM

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE.

CEO

Jacob S. Leach

CEOJacob S. Leach

Employees

11,100

Employees11,100

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1999

Founded1999

Employees

11,100

Employees11,100

DXCM Key Statistics

Market cap

31.06B

Market cap31.06B

Price-Earnings ratio

32.25

Price-Earnings ratio32.25

Dividend yield

—

Dividend yield—

Average volume

6.01M

Average volume6.01M

High today

$85.25

High today$85.25

Low today

$79.79

Low today$79.79

Open price

$81.99

Open price$81.99

Volume

8.63M

Volume8.63M

52 Week high

$92.59

52 Week high$92.59

52 Week low

$54.11

52 Week low$54.11

Stock Snapshot

With a market cap of 31.06B, DexCom(DXCM) trades at $83.50. The stock has a price-to-earnings ratio of 32.25.

As of 2026-11-02, DexCom(DXCM) stock has fluctuated between $79.79 and $85.25. The current price stands at $83.50, placing the stock +4.7% above today's low and -2.0% off the high.

The DexCom(DXCM)'s current trading volume is 8.63M, compared to an average daily volume of 6.01M.

During the past year, DexCom(DXCM) stock moved between $54.11 at its lowest and $92.59 at its peak.

DXCM News

Simply Wall St 2d

DexCom Stock Price Trails Stronger Q3 Earnings Momentum

Dexcom just reported Q3 2026 results with a clear beat on the key factor in diabetes technology profitability, while the stock moved only 3% higher to about US$...

Simply Wall St 2d

DexCom Stock Could Be 41% Undervalued As Guidance Rises

has delivered strong recent gains, yet its longer term record is mixed, which puts the spotlight on whether today's share price is backed by the cash the busine...

Zacks 3d

DexCom Stock Up on Q3 Earnings & Revenue Beat, Margins Rise

DexCom, Inc. (DXCM Quick QuoteDXCM - Free Report) reported third-quarter 2026 adjusted earnings per share (EPS) of 73 cents, which beat the Zacks Consensu...

Analyst ratings

84%

of 32 ratings

Buy

84.4%

Hold

15.6%

Sell

More DXCM News

Simply Wall St 4d

Does Canada CGM Launch Change The Bull Case For DexCom?

DexCom announced that its Health Canada authorized Dexcom G7 15 Day CGM, offering up to 15.5 days of wear with an overall MARD of 8.0%, became available across...

TipRanks 5d

DexCom announces Dexcom G7 15 Day CGM to launch in Canada

Disclaimer: The TipRanks Smart Score performance is based on backtested results. Backtested performance is not an indicator of future actual results. The result...

Simply Wall St 6d

Is DexCom Cheap After CONNECT Trial Results Backed G7 Adoption?

DexCom (DXCM) is back in focus after publishing CONNECT trial data in The New England Journal of Medicine, highlighting clinical benefits of its G7 continuous g...

People also own

Based on the portfolios of people who own DXCM. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.